Eurofarma is the first pharmaceutical company in Social and Environmental Responsibility
Published in: August 9, 2017
and updated in: November 4, 2021
Listen to the text
Stop the audio
Recognized by the Época Negócios Guide 360°
São Paulo, August 09, 2017 - On the night of Tuesday, October 8, the 6th edition of the Época Negócios 360° award was held in São Paulo, which is a Publisher Globo yearbook, which elects the best companies in the country. In the ranking of "Pharmaceutical companies", Eurofarma won the 4th position, with an emphasis to the 1st place in Social and Environmental Responsibility. In the pharmaceutical segment, the first place was achieved by Aché, followed by Libbs and Cristália.
Eurofarma also won the 34th place in the overall ranking, whereas in the ranking that excludes financial performance and maintains the practices of companies in other fields, the company ranked 50th.
In partnership with Fundação Dom Cabral and Boa Vista SCPC, the guide ranks companies from different sectors, evaluating them in six fields: Financial Performance, Human Resources Practices, Socioenvironmental Responsibility, Ability to Innovate, Corporate Governance and Future Vision.
Fibria, from the pulp and paper sector, was elected this year's champion, highlighting its financial health and good management.
About the Eurofarma Group
As the First pharmaceutical multinational with 100% Brazilian capital, Eurofarma has 45 years of existence, 6,500 employees and is present with its own operations in 20 Latin American countries.
With 12 manufacturing plants in the region, the company has more than 280 products in its portfolio. In 2016, it produced more than 290 million units and reached revenues of R$ 3.3 billion, 15.7% higher than the previous one. The Group invests approximately 5.5% of its net sales in Research & Development and maintains in its pipeline more than 175 projects.
About Eurofarma Brasil
Considered one of the best companies to work under the Great Place to Work rank, it is also considered the most sustainable pharmaceutical company in the country, by the Exame Sustainability Guide. With operations in the main pharmaceutical segments such as Medical Prescriptions, Generics, Hospital, Oncology, Veterinary, Bids and Services to Third Parties, Eurofarma holds the largest medical advertising force in Brazil. In all, it has more than 2 thousand representatives who do about 450 thousand medical contacts/month. It is among the 4 largest pharmacies in the country and is the 2nd most prescribed by doctors.
For more information, visit www.eurofarma.com.br
São Paulo, August 09, 2017 - On the night of Tuesday, October 8, the 6th edition of the Época Negócios 360° award was held in São Paulo, which is a Publisher Globo yearbook, which elects the best companies in the country. In the ranking of "Pharmaceutical companies", Eurofarma won the 4th position, with an emphasis to the 1st place in Social and Environmental Responsibility. In the pharmaceutical segment, the first place was achieved by Aché, followed by Libbs and Cristália.
Eurofarma also won the 34th place in the overall ranking, whereas in the ranking that excludes financial performance and maintains the practices of companies in other fields, the company ranked 50th.
In partnership with Fundação Dom Cabral and Boa Vista SCPC, the guide ranks companies from different sectors, evaluating them in six fields: Financial Performance, Human Resources Practices, Socioenvironmental Responsibility, Ability to Innovate, Corporate Governance and Future Vision.
Fibria, from the pulp and paper sector, was elected this year's champion, highlighting its financial health and good management.
About the Eurofarma Group
As the First pharmaceutical multinational with 100% Brazilian capital, Eurofarma has 45 years of existence, 6,500 employees and is present with its own operations in 20 Latin American countries.
With 12 manufacturing plants in the region, the company has more than 280 products in its portfolio. In 2016, it produced more than 290 million units and reached revenues of R$ 3.3 billion, 15.7% higher than the previous one. The Group invests approximately 5.5% of its net sales in Research & Development and maintains in its pipeline more than 175 projects.
About Eurofarma Brasil
Considered one of the best companies to work under the Great Place to Work rank, it is also considered the most sustainable pharmaceutical company in the country, by the Exame Sustainability Guide. With operations in the main pharmaceutical segments such as Medical Prescriptions, Generics, Hospital, Oncology, Veterinary, Bids and Services to Third Parties, Eurofarma holds the largest medical advertising force in Brazil. In all, it has more than 2 thousand representatives who do about 450 thousand medical contacts/month. It is among the 4 largest pharmacies in the country and is the 2nd most prescribed by doctors.
For more information, visit www.eurofarma.com.br